Global Sleep Disorder Treatment Market, By Type (Insomnia, Sleep Apnea, Restless Legs Syndrome (RLS), Narcolepsy and Others), Treatment (Pharmacological Therapy, Mechanical Therapy, Mandibular Advancement Devices, Hypoglossal Nerve Stimulator, Surgery and Others) Route of Administration (Oral, Parenteral and Others), Drugs Type (Branded and Generics), Population Type (Children and Adults), End User (Hospitals, Specialty Clinics, Home Healthcare, Ambulatory Surgical Center and Others), Distribution Channel (Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Others) – Industry Trends and Forecast to 2029
Market Analysis and Size
Sleep disorder, also known as insomnia, is a medical condition in which the patient has difficulty maintaining or initiating sleep. This condition disrupts mental, physical, social, and emotional functions. Furthermore, the introduction of home sleep test kits, as well as the use of wearable monitors and continuous positive airway pressure (CPAP) therapy, expands market opportunities.
Data Bridge Market Research analyses that the sleep disorder treatment market which was USD 8551.42 million in 2021, would rocket up to USD 16914.58 million by 2029, and is expected to undergo a CAGR of 8.90% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Insomnia, Sleep Apnea, Restless Legs Syndrome (RLS), Narcolepsy and Others), Treatment (Pharmacological Therapy, Mechanical Therapy, Mandibular Advancement Devices, Hypoglossal Nerve Stimulator, Surgery and Others) Route of Administration (Oral, Parenteral and Others), Drugs Type (Branded and Generics), Population Type (Children and Adults), End User (Hospitals, Specialty Clinics, Home Healthcare, Ambulatory Surgical Center and Others), Distribution Channel (Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Jazz Pharmaceuticals, Inc. (Ireland), Pfizer Inc. (U.S.), Viatris Inc. (U.S.), Arbor Pharmaceuticals Inc. (U.S.), Aurobindo Pharma USA (U.S.), Sanofi (U.S.), Hikma Pharmaceuticals PLC (U.K.), Amneal Pharmaceuticals LLC (U.S.), Lupin Pharmaceuticals, Inc. (India), Taj Pharmaceuticals Limited (India), Eli Lilly and Company (U.S.), Mallinckrodt (U.K.), Alembic Pharmaceuticals Limited (India), Apotex Inc. (Canada), Dr. Reddy’s Laboratories Ltd. (India), Teva Pharmaceuticals Industries Ltd. (India), Taro Pharmaceutical Industries Ltd. (U.S.), DeVilbiss Healthcare LLC (U.S.), ResMed (U.S.)
|
|
Market Opportunities
|
|
Market Definition
When a patient has a sleep condition, such as sleep apnea, narcolepsy, or insomnia, they may have trouble falling asleep or staying asleep. This condition results in abnormal mental, physical, social, and emotional processes. Many therapeutic approaches are used to treat sleep problems depending on the patients' symptoms.
Sleep disorder treatment Market Dynamics
Drivers
- Rising sleep disorders
The demand for sleep problem treatment alternatives will rise as sleep disorders become more prevalent. Thus, it is projected that increased mental stress brought by a busy lifestyle and bad behaviours will fuel the expansion of the market for treating sleep disorders. Patients may be scared to consume because of the seriousness of the negative effects, which lowers demand and sales. Growing technological development is creating a chance to increase the market's need for sleep problem treatments.
- Rising healthcare spending
Factors that are projected to propel this segment's growth over the forecast period include rising healthcare spending and early diagnosis of the condition due to increased awareness of the alternatives for treatment.
- Increased prevalence of sleep disorders
The global increase in the prevalence of sleep disorders such as sleep apnea, insomnia, and narcolepsy is driving the sleep disorder treatment market.
Opportunities
These elements could play a role in the rising drug demand in these nations. Over the forecast period, demand is anticipated to increase as a result of continually improved healthcare reimbursement policies. Additionally, rising living standards boosted local demand. These variables are predicted to accelerate regional market expansion in the upcoming years.
Restraints/Challenges
The high cost of sleep disorder treatment is a barrier to the market's expansion.
This sleep disorder treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the sleep disorder treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- Jazz Pharmaceuticals plc announced in July 2020 that the FDA had approved its medicine Xyway for the treatment of cataplexy and excessive daytime sleepiness in narcoleptics older than 15 years. The company's new sleep disorder therapy, which was approved by the American FDA, has raised market demand and medicine sales, which will result in higher revenues going forward.
- Armodafinil tablet, a generic form of the medication nuvigil, was introduced by Mylan N.V. in June 2016 to treat individuals who experience excessive sleepiness due to obstructive sleep apnea, narcolepsy, or shift work disorder.
Global Sleep Disorder Treatment Market Scope
The sleep disorder treatment market is segmented on the basis of type, treatment, route of administration, drugs type, population type, end user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Insomnia
- Sleep Apnea
- Restless Legs Syndrome (RLS)
- Narcolepsy
- Others
Treatment
- Pharmacological Therapy
- Mechanical Therapy
- Mandibular Advancement Devices
- Hypoglossal Nerve Stimulator
- Surgery
- Others
Route of Administration
- Oral
- Parenteral
- Others
Drugs Type
- Branded
- Generics
Population Type
- Children
- Adults
End User
- Hospitals
- Specialty Clinics
- Home Healthcare
- Ambulatory Surgical Center
- Others
Distribution Channel
- Direct Tender
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
Sleep Disorder Treatment Market Regional Analysis/Insights
The sleep disorder treatment market is analysed and market size insights and trends are provided by country, type, treatment, route of administration, drugs type, population type, end user and distribution channel as referenced above.
The countries covered in the sleep disorder treatment market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North america is dominating the market due to the growing diagnosis rate and awareness about the disease and people are having a hectic life schedule.
Asia-Pacific is expected to rise due to advancement in new technologies.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Sleep Disorder Treatment Market Share Analysis
The sleep disorder treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to sleep disorder treatment market.
Some of the major players operating in the sleep disorder treatment market are:
- Jazz Pharmaceuticals, Inc. (Ireland)
- Pfizer Inc. (U.S.)
- Viatris Inc. (U.S.)
- Arbor Pharmaceuticals Inc. (U.S.)
- Aurobindo Pharma USA (U.S.)
- Sanofi (U.S.)
- Hikma Pharmaceuticals PLC (U.K.)
- Amneal Pharmaceuticals LLC (U.S.)
- Lupin Pharmaceuticals, Inc. (India)
- Taj Pharmaceuticals Limited (India)
- Eli Lilly and Company (U.S.)
- Mallinckrodt (U.K.)
- Alembic Pharmaceuticals Limited (India)
- Apotex Inc. (Canada)
- Dr. Reddy’s Laboratories Ltd. (India)
- Teva Pharmaceuticals Industries Ltd. (India)
- Taro Pharmaceutical Industries Ltd. (U.S.)
- DeVilbiss Healthcare LLC (U.S.)
- ResMed (U.S.)
SKU-